James Parisi

Enterprise data, analytics, and AI executive with a track record of scaling global organizations, commercializing data capabilities, and driving measurable business growth. Built 6 practices generating $1.5M–$65M in annual revenue, led teams of up to 350 across 15 countries, and exceeded P&L targets for 12 consecutive years. Expertise spans enterprise data strategy, AI transformation and governance, advanced analytics, and technology modernization across Fortune 500 and regulated industries.

Decision Sciences Practice Lead - OMNICOM (TARGETBASE) - Dallas, TX

(2026-04)

Lead decision sciences for a $70B+ U.S. automotive OEM, partnering with marketing and analytics leaders to align AI strategy with acquisition, retention, loyalty, and dealer-service priorities for 40M+ known CDP customers. Launched marketing mix modeling (MMM) and attribution analytics for $200M in annual media spend; reallocated 15% of budget to higher-ROI channels and increased addressable-customer sales by 8% year over year.

• Own the enterprise AI transformation roadmap, including a next-best-action engine across paid and owned channels; established governance covering model accuracy, CCPA compliance, and ROI tracking.
• Modernized third-party data strategy to enrich first-party customer data, predict defection timing, and trigger targeted communications, thereby reducing customer attrition by 4%.
• Integrated customer data and real-time signals into generative AI and MLOps workflows, shortening model refresh cycles from 6 months to 40 days.

Founder & CEO - BLUEBONE - New York, NY

(2022-12 - 2026-04)

Built an AI and analytics services company serving clients in health, wellness, automotive, cannabis, and private equity; developed AI accelerators and an onshore/offshore delivery model while advising C-suites on data strategy, AI governance, and analytics ROI.

• Designed AI transformation roadmaps for 8 clients, establishing governed data foundations, value benchmarks, and executive decision-making dashboards.
• Directed privacy-by-design generative and agentic AI frameworks using OpenAI and Anthropic Claude, reducing time to market for campaigns by up to 25% for pharmaceutical and cannabis clients.
• Applied AI to real-time media performance signals, reducing activation costs by 25% and increasing healthcare professional (HCP) engagement by 35% relative to the pre-optimization baseline.
• Introduced data clean rooms for customer matching and addressable content, increasing match rates by 17%.

EVP, Global Head of Data & Analytics - IPG HEALTH (now Omnicom) - New York, NY

(2021-10 - 2022-11)

Reenvisioned and led enterprise data, analytics, and MarTech strategy for a $2.5B global health network spanning 45 agencies in 15 countries; partnered with CMOs and CIOs on a $30M technology investment roadmap, vendor rationalization, and an AWS cloud migration.

• Transformed the Analytics Center of Excellence from a cost center into a $25M+ ARR product business; streamlined offerings, scaled a 50-person team, reduced attrition, and increased employee satisfaction scores by 75% year over year.
• Mapped HCP journeys across 20+ pharmaceutical brands to optimize omnichannel media investment, resulting in 25% higher HCP engagement.
• Launched a real-world evidence platform that delivers patient and HCP personas and look-alike models, improving targeting effectiveness by 20% and reducing media costs.

SVP, Head of Data & Analytics - INIZIO EVOKE - New York, NY

(2018-01 - 2021-10)

Led data and analytics, media operations, and marketing technology across marketing, public relations, and medical education agencies.

• Improved paid media ROI by 35% for a cardiology medical device by leveraging omnichannel activation, AI-driven decisioning, and predictive analytics.
• Led adherence analysis and prescription-response modeling, informing a CRM solution and increasing patient retention by 28%.
• Directed NLP-based social listening for adverse-event detection, reducing reporting lag from 40 days to 5 days.

VP, Head of Decision Sciences - HAVAS HEALTH & YOU - New York, NY

(2015-06 - 2018-01)

Rebuilt the centralized decision sciences function serving 24 clients across 8 agencies; drove 250% revenue growth over the prior team’s baseline by launching an enterprise predictive analytics platform with data governance.

• Helped secure $80M+ in new business through analytics-led omnichannel campaign strategy and attribution modeling.
• Standardized test-and-learn frameworks for clinical-trial patient-recruitment messaging, improving recruitment performance by 45%.
• Directed cross-channel measurement and programmatic media optimization for a top 5 pharmaceutical client, cutting media waste by 30%.

Head of Marketing Analytics - OMNICOM (HARRISON/STAR) - New York, NY

(2014-09 - 2015-06)

• Launched the agency’s first marketing analytics and media operations departments to measure campaign performance among patients and HCPs.

Pharmaceutical Industry Principal - WIPRO - New Brunswick, NJ

(2012-03 - 2014-06)

• Built a pharmaceutical analytics and Sunshine Act reporting practice from inception to $10M in annual revenue, achieving 400% of the first-year revenue target; established an offshore delivery model compliant with HIPAA and data governance for Fortune 500 pharmaceutical clients.

Pharma & Media Business Unit Head - MU SIGMA - New York, NY

(2008-12 - 2012-02)

• Scaled 350-person global pharmaceutical decision sciences vertical to $65M in annual revenue; designed competency and Agile delivery models that support 10+ pharmaceutical clients. Served on the executive leadership team and evaluated sales opportunities to optimize client win rates, aligning with available resources and expertise.

Earlier Career - IQVIA/Cegedim • comScore

B.A. - Economics - University of Massachusetts Amherst